AAAAAA
Results:
1-12
|
Results: 12
Authors:
Stuyver, LJ
Locarnini, SA
Lok, A
Richman, DD
Carman, WF
Dienstag, JL
Schinazi, RF
Citation: Lj. Stuyver et al., Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region, HEPATOLOGY, 33(3), 2001, pp. 751-757
Authors:
Birch, CJ
McCaw, RF
Bulach, DM
Revill, PA
Carter, JT
Tomnay, J
Hatch, B
Middleton, TV
Chibo, D
Catton, MG
Pankhurst, JL
Bresckin, AM
Locarnini, SA
Bowden, DS
Citation: Cj. Birch et al., Molecular analysis of human immunodeficiency virus strains associated witha case of criminal transmission of the virus, J INFEC DIS, 182(3), 2000, pp. 941-944
Authors:
Locarnini, SA
Civitico, GM
Citation: Sa. Locarnini et Gm. Civitico, Assays for measuring hepadnaviral supercoiled DNA, METH MOL M, 24, 2000, pp. 77-85
Authors:
Shaw, T
Locarnini, SA
Citation: T. Shaw et Sa. Locarnini, Assays for hepatitis B virus DNA- and RNA-dependent DNA polymerase activities, METH MOL M, 24, 2000, pp. 87-95
Authors:
Hardikar, W
Moaven, LD
Bowden, DS
Locarnini, SA
Smith, AL
Citation: W. Hardikar et al., Hepatitis G: viroprevalence and seroconversion in a high-risk group of children, J VIRAL HEP, 6(4), 1999, pp. 337-341
Authors:
Shaw, T
Locarnini, SA
Citation: T. Shaw et Sa. Locarnini, Preclinical aspects of lamivudine and famciclovir against hepatitis B virus, J VIRAL HEP, 6(2), 1999, pp. 89-106
Authors:
Lavanchy, D
Purcell, R
Hollinger, FB
Howard, C
Alberti, A
Kew, M
Dusheiko, G
Alter, M
Ayoola, E
Beutels, P
Bloomer, R
Ferret, B
Decker, R
Esteban, R
Fay, O
Fields, H
Fuller, EC
Grob, P
Houghton, M
Leung, N
Locarnini, SA
Margolis, H
Meheus, A
Miyamura, T
Mohamed, MK
Tandon, B
Thomas, D
Head, HT
Toukan, AU
Van Damme, P
Zanetti, A
Arthur, R
Couper, M
D'Amelio, R
Emmanuel, JC
Esteves, K
Gavinio, P
Griffiths, E
Hallaj, Z
Heuck, CC
Heymann, DL
Holck, SE
Kane, M
Martinez, LJ
Meslin, F
Mochny, IS
Ndikuyeze, A
Padilla, AM
Rodier, GRM
Roure, C
Savage, F
Vercauteren, G
Citation: D. Lavanchy et al., Global surveillance and control of hepatitis C, J VIRAL HEP, 6(1), 1999, pp. 35-47
Authors:
McCaughan, GW
Spencer, J
Koorey, D
Bowden, S
Bartholomeusz, A
Littlejohn, M
Verran, D
Chui, AKK
Sheil, AGR
Jones, RM
Locarnini, SA
Angus, PW
Citation: Gw. Mccaughan et al., Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis withvery low dose hepatitis B immune globulin, LIVER TR S, 5(6), 1999, pp. 512-519
Authors:
Lau, GKK
Carman, WF
Locarnini, SA
Okuda, K
Lu, ZM
Williams, R
Lam, SK
Citation: Gkk. Lau et al., Treatment of chronic hepatitis B virus infection: An Asia-Pacific perspective, J GASTR HEP, 14(1), 1999, pp. 3-12
Authors:
Loi, AG
Faraj, A
Pierra, C
Gosselin, G
Imbach, JL
Locarnini, SA
Groman, EV
Schinazi, RF
Sommadossi, JP
Citation: Ag. Loi et al., Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5 ' monophosphate prodrugs and effectiveness in combination with lamivudine., NUCLEOS NUC, 18(4-5), 1999, pp. 1005-1006
Authors:
Torresi, J
Li, F
Locarnini, SA
Anderson, DA
Citation: J. Torresi et al., Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells, J GEN VIROL, 80, 1999, pp. 1185-1188
Authors:
Nicoll, AJ
Colledge, DL
Toole, JJ
Angus, PW
Smallwood, RA
Locarnini, SA
Citation: Aj. Nicoll et al., Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue, ANTIM AG CH, 42(12), 1998, pp. 3130-3135
Risultati:
1-12
|